Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Dermatology
•
General Dermatology
How do you determine if a pyoderma gangrenosum lesion is “burned out"?
What changes do you make to your treatment approach to adapt to this altered disease state?
Answer from: at Community Practice
The first sign is it becomes much less exudative.
Sign in or Register to read more
24584
Related Questions
Does the presence of psoriatic arthritis affect your decision to use an anti-IL-17 or IL-23 drug in your psoriasis patients?
What is the role of combination antimicrobial, antiviral, and immunomodulatory therapies in managing recurrent erythema multiforme with suspected infectious triggers?
How would you approach treatment failures with squamous cell carcinoma-keratoacanthoma-type lesions that did not respond to a standard SRT regimen after many sessions?
What are some practical tips for caring for resource-limited patients with severe, Hurley Stage III hidradenitis suppurativa?
What is the maximum dose or treatment course of topical steroids that you generally recommend to avoid causing systemic adverse effects?
What laboratory workup do you perform in patients with symptoms consistent with erythromelalgia?
What has been your experience with JAK/STAT inhibitors for granuloma annulare?
What is your treatment algorithm for managing scalp vitiligo?
Is narrow-band ultraviolet B (nbUVB) phototherapy contraindicated or recommended with caution in patients with a personal history of melanoma?
Have you noticed granulomatous reactions becoming more common with the rise in peptide-based and nano-technology topical formulations, along with increased use of resurfacing devices outside of physician oversight?